BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 33847419)

  • 1. Cellular immune responses in the pathophysiology of preeclampsia.
    Miller D; Motomura K; Galaz J; Gershater M; Lee ED; Romero R; Gomez-Lopez N
    J Leukoc Biol; 2022 Jan; 111(1):237-260. PubMed ID: 33847419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leading role for the immune system in the pathophysiology of preeclampsia.
    Laresgoiti-Servitje E
    J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia.
    Aneman I; Pienaar D; Suvakov S; Simic TP; Garovic VD; McClements L
    Front Immunol; 2020; 11():1864. PubMed ID: 33013837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.
    Robillard PY; Dekker G; Scioscia M; Saito S
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S867-S875. PubMed ID: 35177223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.
    Collier AY; Smith LA; Karumanchi SA
    Hum Immunol; 2021 May; 82(5):362-370. PubMed ID: 33551128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity, decidual cells, and preeclampsia.
    Yeh CC; Chao KC; Huang SJ
    Reprod Sci; 2013 Apr; 20(4):339-53. PubMed ID: 22814099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.
    Kopcow HD; Karumanchi SA
    J Reprod Immunol; 2007 Dec; 76(1-2):23-9. PubMed ID: 17490755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immune cells and mediators in preeclampsia.
    Deer E; Herrock O; Campbell N; Cornelius D; Fitzgerald S; Amaral LM; LaMarca B
    Nat Rev Nephrol; 2023 Apr; 19(4):257-270. PubMed ID: 36635411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune cells in the placental bed in healthy pregnancy and preeclampsia.
    Faas MM; De Vos P
    Placenta; 2018 Sep; 69():125-133. PubMed ID: 29748088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells.
    Loewendorf AI; Nguyen TA; Yesayan MN; Kahn DA
    Am J Reprod Immunol; 2015 Sep; 74(3):258-67. PubMed ID: 25962852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.
    Jafri S; Ormiston ML
    Am J Physiol Regul Integr Comp Physiol; 2017 Dec; 313(6):R693-R705. PubMed ID: 28978513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying immune mechanisms mediating the hypertension during preeclampsia.
    LaMarca B; Cornelius DC; Harmon AC; Amaral LM; Cunningham MW; Faulkner JL; Wallace K
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R1-9. PubMed ID: 27097659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response.
    Visser N; van Rijn BB; Rijkers GT; Franx A; Bruinse HW
    Obstet Gynecol Surv; 2007 Mar; 62(3):191-201. PubMed ID: 17306041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preeclampsia as a maternal vascular disease].
    Amash A; Huleihel M; Sheiner E; Sapir O; Holcberg G
    Harefuah; 2007 Sep; 146(9):707-12, 733. PubMed ID: 17969310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.
    Cubro H; Kashyap S; Nath MC; Ackerman AW; Garovic VD
    Curr Hypertens Rep; 2018 Apr; 20(4):36. PubMed ID: 29713810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective.
    Bueno-Sánchez JC; Gómez-Gutiérrez AM; Maldonado-Estrada JG; Quintana-Castillo JC
    Front Endocrinol (Lausanne); 2023; 14():1087845. PubMed ID: 37206444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic characteristics of preeclampsia, a comprehensive review.
    Ahn H; Park J; Gilman-Sachs A; Kwak-Kim J
    Am J Reprod Immunol; 2011 Apr; 65(4):377-94. PubMed ID: 20825381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.